Respiratory Outbreak Mitigation in Long-Term Care Using Point-of-Care Testing
NCT06660433 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 24
Last updated 2025-12-02
Summary
Outbreaks of seasonal respiratory viruses can spread rapidly in long-term care homes. Timely results for diagnostic tests remains a challenge for respiratory viruses due to the logistics of using a reference laboratory with delays leading to missed opportunities to implement virus-specific control measures to interrupt transmission resulting in larger outbreaks. Use of a point-of-care testing platform is a potential solution that provides faster results, but it is uncertain whether this translates into benefits for long-term care residents. This trial aims to assess whether rapid test results for respiratory pathogens (Influenza, Coronavirus disease of 2019 (COVID-19) and Respiratory Syncytial Virus) can impact the number and size of respiratory virus outbreaks in long-term care homes.
Conditions
- Outbreaks
Interventions
- DEVICE
-
Point-of-care respiratory test platform
A point-of-care respiratory multiplex testing platform situated within a long-term care facility to provide rapid test results
- OTHER
-
Existing respiratory virus testing platform
Currently used respiratory virus testing platforms
Sponsors & Collaborators
-
Sunnybrook Health Sciences Centre
collaborator OTHER -
Humber River Health
collaborator UNKNOWN -
Michael Garron Hospital
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- HEALTH_SERVICES_RESEARCH
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-11-11
- Primary Completion
- 2025-05-30
- Completion
- 2026-03-31
Countries
- Canada
Study Locations
More Related Trials
-
TEM-PCR™ Prospective Clinical Utility Study
NCT04248361 ·Status: SUSPENDED ·Phase: PHASE4
-
Covid-19 Breath Test
NCT04459962 ·Status: COMPLETED ·Phase: NA
-
Looking for Asymptomatic Mpox in a Population at High Risk
NCT06353737 ·Status: RECRUITING
-
POC SARS-CoV-2 Diagnostic PCR Device Comparison to FDA Approved Reference PCR Test
NCT04981769 ·Status: UNKNOWN
-
Monitoring Patients for Developing Communicable and Opportunistic Infections and for Responding to Therapy
NCT00001477 ·Status: COMPLETED
-
Impact on PCT+ FilmArray RP2 Plus Use in LRTI Suspicion in Emergency Department
NCT03840603 ·Status: COMPLETED ·Phase: NA
-
Role of Multiplex PCR in CAP
NCT06097117 ·Status: NOT_YET_RECRUITING
-
POCT PCT in Outpatient LRTI
NCT05380869 ·Status: COMPLETED ·Phase: NA
-
Clinical Performance Study for EDAN's COVID-19/Flu A/Flu B/RSV Test Kits on Subjects Suspected of Respiratory Infection
NCT06175611 ·Status: RECRUITING
-
Point-of-Care Multiplex for Adult Patients With Severe Community-acquired Pneumonia
NCT04835818 ·Status: UNKNOWN ·Phase: NA
-
A Clinical Evaluation of Proof Diagnostics Test System Including the Proof Diagnostics Reader and COVID-19 Test
NCT05331976 ·Status: COMPLETED
-
Viral Testing and Biomarkers to Reduce Antibiotic Use for Respiratory Infections
NCT01907659 ·Status: COMPLETED ·Phase: NA
-
Impact of a Regional Antimicrobial Stewardship on the Length of Stay of Patients Admitted to Hospital With Pneumonia
NCT02276092 ·Status: COMPLETED
-
Fast Identification of Pathogen in the Setting of Pneumonia Using Multiplex PCR
NCT01858974 ·Status: COMPLETED
-
Rapid Viral Diagnostics in Adults to Reduce Antimicrobial Consumption and Duration of Hospitalization
NCT02538770 ·Status: COMPLETED ·Phase: NA
-
Screening for COVID-19
NCT04615208 ·Status: WITHDRAWN
-
Point of Care Testing Using FebriDx in Primary Care: a Mixed Methods Feasibility Study
NCT05534555 ·Status: UNKNOWN ·Phase: NA
-
SARS-CoV-2 and Influenza A/B in Point-of-Care and Non-Laboratory Settings
NCT06191393 ·Status: COMPLETED ·Phase: NA
-
An Algorithm to Decide on Antibiotic Prescription in Lower Respiratory Tract Infection in Primary Care
NCT03191071 ·Status: COMPLETED ·Phase: NA
-
Performance Evaluation of the LumiraDX SARS-CoV-2 Ag Ultra and LumiraDX SARS-CoV-2 & Flu A/B Tests at Point of Care (POC) Sites
NCT05728970 ·Status: COMPLETED
-
FebriDx® Method Comparison Study Protocol
NCT06746259 ·Status: COMPLETED
-
Study on Costs and Safety of Early Conversion From Intravenous to Oral Antibiotic Treatment in Patients With Severe Community-Acquired Pneumonia
NCT00273676 ·Status: COMPLETED ·Phase: PHASE4
-
Clinical Validation of Breath Analyser Tests for Diagnosis of COVID-19.
NCT05094674 ·Status: UNKNOWN ·Phase: NA
-
Detecting Respiratory Viruses in Upper and Lower Respiratory Tract Samples
NCT01597089 ·Status: TERMINATED
-
Performance Evaluation of LumiraDx COVID-19 (SARS-CoV-2) Ag Test
NCT04557046 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA